Novo Nordisk shares surge as weight loss treatments boost profits
Europe's largest pharmaceutical firm, Novo Nordisk, reported fourth-quarter earnings that surpassed analysts' expectations. The company’s shares jumped more than 6% at the market open in Europe following the results. Its stock remains flat in year-to-date performance.


